Larynx Cancer
44
7
10
24
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.8%
3 terminated out of 44 trials
88.9%
+2.4% vs benchmark
9%
4 trials in Phase 3/4
21%
5 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (44)
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
Phonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
CONFIRM: Magnetic Resonance Guided Radiation Therapy
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors
CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)
Evaluations of Alcohol Warning Labels
Pembrolizumab in Combination With CRT for LA-SCCHN
VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLaryngectomy
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer
The Registry of Oncology Outcomes Associated with Testing and Treatment
WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer
GI Organ Tracking Via Balloon Applicators
Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy
A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers